熱門資訊> 正文
X4 Pharmaceuticals获得6000万美元PIPE融资
2025-08-12 21:49
- X4 PHARMACEUTICALS INC(XFOR) 0
- Invesco Actively Managed Exchange-Traded Fund Trust Invesco SteelPath MLP & Energy Infrastructure ETF(PIPE) 0
- 纳比特(NA) 0
- X4 Pharmaceuticals (NASDAQ:XFOR) has entered into a $60 million PIPE financing deal, expected to close around August 13, 2025, pending customary conditions.
- The company will issue 11,040,776 shares at $1.42 each, or pre-funded warrants for up to 31,234,731 shares at $1.419 each, with a $0.001 exercise price and no expiration.
- Proceeds will fund further development of mavorixafor for chronic neutropenia and support the commercialization of WHIM.
- X4 Pharmaceuticals shares rose 30%.
More on X4 Pharmaceuticals
- X4 Pharmaceuticals gains on fast-track designation for mavorixafor for treatment of chronic neutropenia
- Seeking Alpha’s Quant Rating on X4 Pharmaceuticals
- Historical earnings data for X4 Pharmaceuticals
- Financial information for X4 Pharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
